Nexus Pharmaceuticals Announces Launch of Tacrolimus Injection
We’re proud to share the news of our latest product launch: Tacrolimus Injection, USP 5 mg/mL, now available in a single-dose vial format. This critical immunosuppressant is indicated for the prevention of organ rejection in liver and kidney transplant patients, offering healthcare providers a new, cost-effective option in a convenient presentation. This launch represents another step […]